Anticholinergic antispasmodic

5 marketed 5 in Phase 3 1 in Phase 1

This page covers all Anticholinergic antispasmodic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Muscarinic acetylcholine receptors (M1-M5), Muscarinic acetylcholine receptors, Muscarinic receptors.

Targets

Muscarinic acetylcholine receptors (M1-M5) · Muscarinic acetylcholine receptors · Muscarinic receptors · Phosphodiesterase; calcium channels · Calcium channels (L-type); smooth muscle relaxant · Acetylcholine receptor

Marketed (5)

Phase 3 pipeline (5)

Phase 1 pipeline (1)

Patent intelligence